Target Name: SIMC1
NCBI ID: G375484
Other Name(s): MGC33586 | C5orf25 | PLEIAD | FLJ56998 | SIMC1_HUMAN | Uncharacterized protein C5orf25 | SIMC1 variant 1 | SIMC1 variant 2 | SIMC1 variant 3 | SUMO interacting motifs containing 1, transcript variant 2 | Oocyte maturation associated 1 | SUMO interacting motifs containing 1, transcript variant 3 | MGC40402 | SUMO-interacting motif-containing protein 1 | SUMO interacting motifs containing 1 | SUMO-interacting motif-containing protein 1 (isoform a) | SUMO-interacting motif-containing protein 1 (isoform c) | Platform element for inhibition of autolytic degradation | oocyte maturation associated 1 | SUMO interacting motifs containing 1, transcript variant 1 | OOMA1 | OTTHUMP00000202935 | FLJ44216 | OTTHUMP00000161247 | MGC90345 | FLJ52236 | SUMO-interacting motif-containing protein 1 (isoform b) | platform element for inhibition of autolytic degradation

SIMC1: Potential Drug Targets for Cell Signaling, Inflammation and Tissue Development

SIMC1 (MGC33586) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the SIM gene family, which encodes for small subunits of the protein sim domain. SIMC1 is known for its role in cell signaling and is involved in a number of different cellular processes, including cell adhesion, migration, and invasion.

One of the unique features of SIMC1 is its ability to interact with a variety of different proteins, including the protein known as FAK. This interaction between SIMC1 and FAK has been shown to play a role in the regulation of cellular processes such as cell growth, differentiation, and survival.

SIMC1 has also been shown to be involved in the regulation of inflammation. In particular, SIMC1 has been shown to be involved in the regulation of the chemokine, which is a molecule that is involved in the recruitment of immune cells to sites of infection or injury . This suggests that SIMC1 may be a potential drug target for the treatment of inflammatory diseases.

Another potential function of SIMC1 is its role in the regulation of cell death. SIMC1 has been shown to be involved in the regulation of cell apoptosis, which is the process by which cells die as a result of various factors, including DNA damage, oxygen deprivation , and exposure to toxins. This suggests that SIMC1 may be a potential drug target for the treatment of diseases that are characterized by cellular dysfunction or death, such as neurodegenerative diseases.

In addition to its potential functions in cell signaling and inflammation, SIMC1 has also been shown to be involved in the regulation of cellular processes that are important for tissue development and maintenance. For example, SIMC1 has been shown to be involved in the regulation of cell proliferation, which is the process by which cells grow and divide. This suggests that SIMC1 may be a potential drug target for the treatment of diseases that are characterized by uncontrolled cell growth, such as cancer.

Another potential function of SIMC1 is its role in the regulation of cellular processes that are important for the development and maintenance of tissues. For example, SIMC1 has been shown to be involved in the regulation of cell migration, which is the process by which cells move from one location to another in order to perform specific functions. This suggests that SIMC1 may be a potential drug target for the treatment of diseases that are characterized by uncontrolled cell migration, such as cancer.

In conclusion, SIMC1 is a protein that is involved in a number of different cellular processes that are important for the development and maintenance of tissues. Its ability to interact with a variety of different proteins, including FAK and chemokines, suggests that SIMC1 may be a potential drug target for the treatment of a wide range of diseases. Its involvement in cell signaling, inflammation, and apoptosis also suggests that SIMC1 may be a potential target for diseases that are characterized by cellular dysfunction or dysfunctional regulation.

Protein Name: SUMO Interacting Motifs Containing 1

Functions: Inhibits the protease activity of CAPN3

More Common Targets

SIN3 complex | SIN3A | SIN3B | SINHCAF | SIPA1 | SIPA1L1 | SIPA1L1-AS1 | SIPA1L2 | SIPA1L3 | SIRPA | SIRPAP1 | SIRPB1 | SIRPB2 | SIRPB3P | SIRPD | SIRPG | SIRPG-AS1 | SIRT1 | SIRT2 | SIRT3 | SIRT4 | SIRT5 | SIRT6 | SIRT7 | SIT1 | SIVA1 | SIX1 | SIX2 | SIX3 | SIX3-AS1 | SIX4 | SIX5 | SIX6 | SKA1 | SKA1 complex | SKA2 | SKA2P1 | SKA3 | SKAP1 | SKAP1-AS2 | SKAP2 | Skeletal muscle troponin | SKI | SKIC2 | SKIC3 | SKIC8 | SKIDA1 | SKIL | SKINT1L | SKOR1 | SKOR2 | SKP1 | SKP1P2 | SKP2 | SLA | SLA2 | SLAIN1 | SLAIN2 | SLAM Family Member | SLAMF1 | SLAMF6 | SLAMF6P1 | SLAMF7 | SLAMF8 | SLAMF9 | SLBP | SLC corepressor complex | SLC10A1 | SLC10A2 | SLC10A3 | SLC10A4 | SLC10A5 | SLC10A6 | SLC10A7 | SLC11A1 | SLC11A2 | SLC12A1 | SLC12A2 | SLC12A2-DT | SLC12A3 | SLC12A4 | SLC12A5 | SLC12A5-AS1 | SLC12A6 | SLC12A7 | SLC12A8 | SLC12A9 | SLC13A1 | SLC13A2 | SLC13A3 | SLC13A4 | SLC13A5 | SLC14A1 | SLC14A2 | SLC15A1 | SLC15A2 | SLC15A3 | SLC15A4 | SLC15A5 | SLC16A1